Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

NIH 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 100Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Monocytic, Acute 14Leukemia, Myelomonocytic, Acute 13Leukemia, Erythroblastic, Acute 12Leukemia, Megakaryoblastic, Acute 11Congenital Abnormalities 11Leukemia, Promyelocytic, Acute 9Recurrence 8Leukemia, Biphenotypic, Acute 7Carcinoma, Hepatocellular 7Leukemia, Myelomonocytic, Chronic 6Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Anemia, Refractory, with Excess of Blasts 5Lymphoma 4Blast Crisis 4Neoplasm, Residual 3Lymphoma, Large B-Cell, Diffuse 3Liver Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lung Neoplasms 2

Interventions

Cytarabine 8Filgrastim 4Cyclophosphamide 4Clofarabine 4Radiotherapy 3Idarubicin 3eltrombopag 2Thiotepa 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Imatinib Mesylate 2Genetic Testing 2Gene Expression Profiling 2Etoposide 2Daunorubicin 2Arsenic Trioxide 2Antilymphocyte Serum 2tipifarnib 1temsirolimus 1midostaurin 1fludarabine phosphate 1dexamethasone acetate 1aldesleukin 1Whole-Body Irradiation 1Reverse Transcriptase Polymerase Chain Reaction 1Proto-Oncogene Proteins c-kit 1Mitoxantrone 1Microarray Analysis 1Methoxsalen 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Leukemia, Eosinophilic, Acute × Idarubicin × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01154439 2022-10-26

AML1208

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 1 Completed
11 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00093483 2014-01-13

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 1 Completed
61 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡